GLAXOSMITHKLINE PHARMACEUTICALS LTD. Q3 FY25 Results
GLAXOQ3 FY25 ResultsAnnounced 14 Feb 2025, 03:27 pm| Metric | Value (₹ Cr) | vs Q2 FY25 |
|---|---|---|
| Revenue | 949.42 | 6.1% |
| Total Income | 984.49 | 5.8% |
| Expenditure | 676.39 | 4.2% |
| PBT | 308.10 | 10.4% |
| Net Profit | 229.88 | 9.0% |
| OPM | 26.77% | 2.13pp |
| NPM | 23.35% | 0.81pp |
| EPS | 13.57 | 7.5% |
Informational and educational content only. Not investment advice.